« Back to Record
Citation APA

van der Werff Ten Bosch, J., Suciu, S., Thyss, A., Bertrand, Y., Norton, L., Mazingue, F., Uyttebroeck, A., Lutz, P., Robert, A., Boutard, P., Ferster, A., Plouvier, E., Maes, P., Munzer, M., Plantaz, D., Dresse, M.-F., Philippet, P., Sirvent, N., Waterkeyn, C., Vilmer, E., Philippe, N., & Otten, J. (2005). Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG. Leukemia, 19(5), 721-726. doi:10.1038/sj.leu.2403689


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/96491

van der Werff Ten Bosch, J., Suciu, S., Thyss, A., Bertrand, Y., Norton, L., Mazingue, F., Uyttebroeck, A., Lutz, P., Robert, A., Boutard, P., Ferster, A., Plouvier, E., Maes, P., Munzer, M., Plantaz, D., Dresse, M.-F., Philippet, P., Sirvent, N., Waterkeyn, C., Vilmer, E., Philippe, N., & Otten, J. (2005). Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG. Leukemia, 19(5), 721-726. doi:10.1038/sj.leu.2403689